Leveraging eCOA Technologies to Create Greater Patient Centricity
In part 3 of this video interview, Kristy Birchard, product owner, patient engagement, YPrime touches on the importance of utilizing patient-reported outcomes.
ACT: How can sponsors leverage electronic clinical outcome assessment (eCOA) technologies to facilitate the collection and management of patient-reported outcomes (PROs)? How does this contribute to a more patient-centric approach?
Birchard: I am actually such a big fan of ePROs. I've been working in the clinical trial industry for eight, nine years now, because after graduate school, I was focusing on patient-centric research design, and I really wanted to find a space where that was happening, and in the clinical trial space, especially in the ePRO space, was where I saw the most influential work being done—incorporating patient and caregiver knowledge as a crucial part of science and understanding knowledge as both live knowledge and scientific knowledge. It was really exciting for me to get into this space. I always say I'm a patient first. That's why I got into this industry.
Patient-reported outcomes allow patients to report symptoms at home, they allow patients a lot more convenience and flexibility of how they report symptoms. Also, the biggest part for me is that they actually often, if done right, and in a patient centric way give patients a voice that they're not always granted in in our system. I really strongly believe that ePROs specifically have so much value in the clinical trial industry because, again, they give patients more opportunities to use these tools as a voice and a way to report how we're living with or managing our illnesses. I think that, in itself, is crucial to the conversation of patient centricity and building these tools with patients is also very important.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025